The cacao swollen shoot virus disease is among the most economically damaging diseases of cacao trees and accounts for almost 15-50% of harvest losses...
In a new retrospective cohort study, scientists at the University of Texas Health Science Center at Houston found that, through an uncertain mechanism,...
A single-dose intranasal vaccine called ChAd-SARS-CoV-2-S prevents SARS-CoV-2 infection in both the upper and lower respiratory tracts of mice, according...
Dr. Lisa Jackson of Kaiser Permanente Washington Health Research Institute in Seattle and colleagues conducted a first-in-human Phase 1 clinical trial...
Dr. Paul Fidel, Jr., from Louisiana State University Health – School of Dentistry and Professor Mairi Noverr from Tulane University School of Medicine...
In a paper published in the journal Frontiers in Microbiology, a team of researchers at the University of North Carolina at Chapel Hill review possible...
The race is on to develop a vaccine that can protect us from the COVID-19 pandemic. An impressive 115 vaccine candidates are currently being investigated,...
Researchers at the Commonwealth Scientific and Industrial Research Organisation (CSIRO) have developed a new visualization platform, underpinned by bioinformatics...
A team of researchers at the University of Pittsburgh and Erasmus Medical Center Rotterdam has developed a potential vaccine against SARS-CoV-2, a novel...
Since humans haven’t previously been exposed to the SARS-CoV-2 coronavirus, our bodies aren’t well equipped to deal with being infected by it. A vaccine...
Two new papers published in the journal Antimicrobial Agents and Chemotherapy provide a summary of therapeutic compounds that showed potential in fighting...
Researchers from CAS, a division of the American Chemical Society, have released a special report in which they provide an overview of previously published...
According to a paper published in the journal Clinical Infectious Diseases, adults do not need tetanus or diphtheria boosters if they’ve already completed...
Researchers have made a breakthrough toward developing a vaccine for the SARS-CoV-2 coronavirus, also known as 2019-nCoV, by creating the first 3D atomic...
The new biofilm-specific vaccine, developed by researchers from the University of Maryland-Baltimore, Northern Arizona University and the University of...
A team of scientists at the University of Pennsylvania has developed a new vaccine candidate to protect against herpes simplex virus type 2 (HSV-2), the...
A research team led by Flinders University’s Professor Nikolai Petrovsky has completed a human clinical trial on an adjuvant vaccine designed to eliminate...
A common food additive called tert-butylhydroquinone (E319) suppresses the immune response the body mounts when fighting the flu; it also reduces the effectiveness...
An international team of scientists from the UK, Switzerland and Latvia has developed a virus-like particle vaccine that could be used to treat chronic...
